Basilea Pharmaceutica Investor Relations Material
Latest events
H2 2023
Basilea Pharmaceutica
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Basilea Pharmaceutica AG
Access all reports
Basilea Pharmaceutica Ltd. operates as a commercial stage biopharmaceutical company in the United States and internationally. The company focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives, and various supportive care products for cancer patients undergoing chemotherapy treatment or for those being treated with antibiotics. It also develops ceragenin technology to treat hospital acquired bacterial infections; and CRAPOMICIN, a novel, semi-synthetic lipoglycopeptide antibiotic candidate, which is in clinical development for complicated skin and soft tissue infections, including acute bacterial skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus bacteria, as well as ventilator associated pneumonia caused by Gram negative bacteria.
Key slides for Basilea Pharmaceutica AG
H2 2023
Basilea Pharmaceutica AG
H2 2023
Basilea Pharmaceutica AG
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇨🇭 Switzerland